| 0 |
Selective T Cell Costimulation Blocker [EPC] |
9 |
0.0019 |
| 1 |
Anthelmintic [EPC] |
2 |
0.0007 |
| 2 |
Antiparasitic [EPC] |
2 |
0.0004 |
| 3 |
Pediculicide [EPC] |
2 |
0.0004 |
| 4 |
Neonatal Fc Receptor Blocker [EPC] |
1 |
0.0002 |
| 5 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
3 |
0.0002 |
| 6 |
Antimalarial [EPC] |
2 |
0.0002 |
| 7 |
Antiprotozoal [EPC] |
2 |
0.0002 |
| 8 |
Echinocandin Antifungal [EPC] |
1 |
0.0001 |
| 9 |
Lipopeptide Antibacterial [EPC] |
1 |
0.0001 |
| 10 |
Carbonic Anhydrase Inhibitor [EPC] |
2 |
0.0001 |
| 11 |
Antimetabolite Immunosuppressant [EPC] |
2 |
0.0001 |
| 12 |
Sympathomimetic-like Agent [EPC] |
3 |
0.0001 |
| 13 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0001 |
| 14 |
Lipid-based Polyene Antifungal [EPC] |
1 |
0.0001 |
| 15 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
1 |
0.0001 |
| 16 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
3 |
0.0001 |
| 17 |
Glycopeptide Antibacterial [EPC] |
4 |
0.0001 |
| 18 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 19 |
Human Immunoglobulin G [EPC] |
1 |
0.0000 |
| 20 |
Protease Inhibitor [EPC] |
2 |
0.0000 |
| 21 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
4 |
0.0000 |
| 22 |
Integrin Receptor Antagonist [EPC] |
3 |
0.0000 |
| 23 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 24 |
Phenothiazine [EPC] |
1 |
0.0000 |
| 25 |
Cytochrome P450 3A Inhibitor [EPC] |
2 |
0.0000 |
| 26 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1 |
0.0000 |
| 27 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 28 |
Catecholamine [EPC] |
2 |
0.0000 |
| 29 |
Selective T Cell Costimulation Modulator [EPC] |
3 |
0.0000 |
| 30 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 31 |
Purine Antimetabolite [EPC] |
2 |
0.0000 |
| 32 |
CD20-directed Cytolytic Antibody [EPC] |
6 |
0.0000 |
| 33 |
Corticosteroid [EPC] |
24 |
0.0000 |
| 34 |
Opioid Agonist [EPC] |
5 |
0.0000 |
| 35 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 37 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 38 |
Aldosterone Antagonist [EPC] |
2 |
0.0000 |
| 39 |
Arteriolar Vasodilator [EPC] |
1 |
0.0000 |
| 40 |
Phosphodiesterase 4 Inhibitor [EPC] |
2 |
0.0000 |
| 41 |
Proton Pump Inhibitor [EPC] |
7 |
0.0000 |
| 42 |
Folate Analog Metabolic Inhibitor [EPC] |
5 |
0.0000 |
| 43 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 44 |
Interferon beta [EPC] |
2 |
0.0000 |
| 45 |
Thalidomide Analog [EPC] |
5 |
0.0000 |
| 46 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |
| 47 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 48 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 49 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 50 |
Calcium [EPC] |
1 |
0.0000 |
| 51 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 52 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 53 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
6 |
0.0000 |
| 54 |
Alkylating Drug [EPC] |
1 |
0.0000 |
| 55 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 56 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 57 |
Vitamin B12 [EPC] |
1 |
0.0000 |
| 58 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 59 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 60 |
Loop Diuretic [EPC] |
1 |
0.0000 |
| 61 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |
| 62 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 63 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 64 |
Benzodiazepine [EPC] |
1 |
0.0000 |
| 65 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |